Dental hygiene tips for healthy teeth & gums

A young patient lost the nerve in a front tooth after a bike accident, before the root had even finished forming. A pediatric dentist treating the case knew that twenty years ago, the standard fix was a root canal, one that would have left the root exactly as underdeveloped as it was that day.
Instead, the root kept growing after treatment, closing and thickening the way it would have if the injury had never happened. That’s regenerative dentistry, a tooth doing something a standard root canal was never built to let it do.
Traditional dental treatment patches damage with something artificial, metal, composite, or ceramic. Regenerative dentistry starts from a completely different idea – using the body’s own cells to rebuild tissue that would otherwise be gone permanently.
Dental pulp turns out to be an unusually convenient source for this. A PMC review on dental pulp stem cells describes them as mesenchymal stem cells with the ability to self-renew and differentiate into multiple tissue types, sitting inside a part of the body that’s relatively easy to access compared to bone marrow or other stem cell sources. That accessibility is a big part of why dental regeneration has moved faster than some other areas of regenerative medicine.
Multiple sources exist, each with its own name and its own use case in dental regeneration.
Dental pulp stem cells (DPSCs). Harvested from the pulp of permanent teeth, typically ones already being extracted for other reasons like wisdom teeth removal. A PMC review on DPSCs in bone tissue engineering notes their high proliferation rate and low immune reactivity, along with an unusual ability to form functional dentin-pulp complexes rather than just generic connective tissue.
SHED cells. These come from baby teeth, specifically the ones that fall out on their own rather than being pulled. A growing number of families are choosing to bank them when a child loses a tooth, the same logic behind cord blood banking.
Periodontal ligament stem cells (PDLSCs). These live in the ligament that anchors a tooth root to the jawbone. Periodontal tissue engineering leans on them heavily, since gum disease destroys exactly the kind of structure PDLSCs are good at rebuilding.
For a specific patient population, yes, and the outcome data is fairly strong. A systematic review and meta-analysis covering randomized controlled trials found success rates around 95.6 percent for regenerative endodontic procedures in necrotic immature teeth, with asymptomatic rates just above that. Traditional apexification, the older approach for these same teeth, doesn’t offer anything close to that continued root development.
A separate systematic review focused specifically on trauma cases found survival and success rates of 93.8 and 88.3 percent for traumatized necrotic immature teeth treated this way. There’s a real tradeoff worth knowing about, too. Crown discoloration showed up in over 60 percent of cases in one analysis, a cosmetic side effect tied to the materials used during treatment, worth hearing about upfront.
The procedure itself works by triggering bleeding from tissue beyond the root tip, forming a blood clot inside the canal that acts as a scaffold. Stem cells already present at the root apex use that scaffold to rebuild pulp-like tissue and keep the root developing, which is the core idea behind regenerative dentistry in this context, and something a filled and sealed canal simply doesn’t do.
A systematic review in PMC on dental pulp stem cells for alveolar and jaw bone reconstruction looked specifically at combining these cells with scaffold materials for bone regeneration in animal models. The review’s own framing is honest about where things stand. Most of the evidence so far comes from animal studies rather than large human trials, and the added benefit of cells over scaffold alone hasn’t been systematically nailed down yet.
Periodontal tissue engineering follows a similar pattern. A PMC review on dental pulp stem cells in periodontal regeneration covers ongoing work combining these cells with scaffolds and growth factors to rebuild structures periodontitis destroys, bone, ligament, and cementum together rather than one at a time. Chronic gum disease has always meant permanent structural loss up until now. Reversing that, not just speeding up healing from damage already done, is what regenerative dentistry is actually aiming at here.
Dental stem cells turn out to be useful in places that have nothing to do with teeth. A systematic review on dental pulp stem cells in regenerative therapies lists applications explored in neurotrauma, autoimmune conditions, myocardial infarction, and muscular dystrophy, alongside the more expected dental and craniofacial uses.
Most of this cross-application research is early and exploratory, with animal models and small pilot studies rather than approved treatments. That gap between research and reality is worth remembering, since a tooth extraction offering a low-risk way to bank cells doesn’t mean regenerative dentistry has already become a general medical treatment. It does explain why interest in banking has grown well beyond dentistry specifically.
Ask about the track record with the specific procedure. Regenerative endodontics, in particular, has enough protocol variation between practitioners, disinfection methods, scaffold choice, and medication used that outcomes can differ meaningfully depending on who’s doing it.
Ask about discoloration risk directly if it’s a front tooth, since that side effect shows up often enough to plan around. And ask what happens if the regenerative dentistry approach doesn’t take. A backup plan should be part of the conversation before treatment even starts, usually a standard root canal or apexification if the regenerative approach doesn’t pan out.
Mostly, for the endodontic version specifically, since root development is the main advantage over a standard root canal. Research is expanding into mature teeth too, though the vitality benefits look different there.
Yes, typically at the time of an extraction, like wisdom teeth removal, through private stem cell banking services. It’s a separate decision from any specific treatment and comes with its own ongoing storage cost.
Not usually. Coverage really depends on the provider and plan. The best bet is to have your dentist’s office check ahead of time.
Regenerative endodontic procedures have a real clinical track record by now, close to two decades of published outcomes. The bone and periodontal side of things is a lot newer, still mostly animal studies working toward wider clinical use.
Regenerative dentistry is already changing what happens to a young patient’s tooth after trauma, in dental offices already using these protocols today. Bone and periodontal regeneration are following a step or two behind, still mostly in the research stage but moving fast enough that today’s animal study is often tomorrow’s small clinical trial.
If a dentist brings up a regenerative option for you or your child, ask specifically what the track record looks like at that practice, and what the plan is if it doesn’t work as hoped. Both answers are worth having before deciding, especially with a front tooth in play.